← All medicines

Breathing and allergy

Mepolizumab injection

Independent educational summary · Sources checked November 20, 2026

An antibody for selected eosinophilic respiratory or systemic conditions, including eligible asthma or COPD settings; it is not acute rescue treatment.

Profile scope: Mepolizumab injection. Confirm the exact product and route; formulations and combination products are not interchangeable.

Possible side effects

Injection reactions, headache, skin symptoms, body discomfort, or diarrhea may occur.

Serious risks and warning signs

Serious allergy can cause swelling, hives, breathlessness, or fainting and requires emergency help. Infection and parasite history and vaccine considerations need review. Other controller or steroid medicines should only change under a coordinated plan.

A question for your healthcare team

Which existing medicines must continue, and what allergy, vaccine, and infection precautions apply?

What to do with this information

Discuss persistent or troubling symptoms with your prescriber or pharmacist. For severe breathing difficulty, collapse, a seizure, or inability to wake someone, seek emergency help. Read the linked medicine information for drug-specific instructions, including situations requiring immediate action. For routine treatment changes, consult your prescriber rather than changing your dose on your own. Follow the urgent action instructions above and in the linked medicine information.

Sources

Sources checked November 20, 2026. An original AI-assisted educational summary, not a complete adverse-effect or interaction list. This profile is part of the broader library expansion, not the original prescription-use ranking. Inclusion does not confirm current product availability or mean that risks outweigh benefits. This page has not been independently reviewed by a clinician.